LONDON, April 03, 2023--(BUSINESS WIRE)--C3 AI (NYSE: AI), the Enterprise AI application software company, has today announced the relocation of their European, Middle East and Africa (EMEA) headquarters from Paris, France to London, United Kingdom. "Our new EMEA headquarters represents an important next step for C3 AI," said C3 AI CEO Thomas M. Siebel. "As a global company, we are proud to call London our EMEA base and we look forward to the opportunity for even closer collaboration with the UK's world-class technology and artificial intelligence experts, businesses, and institutions." C3 AI has had a presence in Europe since the company's inception in 2009, with offices currently located in London, Paris, Munich, Rome, and Amsterdam. The decision to relocate the central EMEA operation to London ties in with the business's ambitious 2023 targets.

Andrew Rickman, CEO of Rockley explains why wearables will be at the heart of a healthcare revolution in 2023. A revolution is coming to healthcare--and soon. Over the next year, wearable devices and the advanced sensors and AI technologies that work with them will transform healthcare for millions of patients, enabling them to avoid many serious health conditions and better diagnose and manage a range of chronic illnesses. Deloitte Global forecasts that 320 million health and wellness wearables will ship to consumers worldwide in 2022. By 2024, it says, that number will rise to almost 440 million as new devices are released, and healthcare providers grow more comfortable with them.

Deepak Gaddipati is founder and chief technology officer at VirtuSense, an artificial intelligence company that aims to transform healthcare from reactive to proactive by alerting care teams to adverse events such as falls, sepsis and heart attacks before they occur. Gaddipati invented the first commercial full-body, automated, AI-powered scanning system, which is widely deployed across most U.S. airports. He is steeped in the power of AI. Healthcare IT News sat down with Gaddipati to discuss some of his work in healthcare with AI and where he sees the technology headed. You invented the full-body scanning system.

The pandemic is now two years old. A population the size of Finland has so far died from COVID-19 and tens of millions more are dealing with its side-effects. Even for those who haven't fallen seriously ill, nearly every aspect of our lives has been disrupted by COVID-19: from how we socialize and communicate, to how we study and work. We are all familiar with the crisis, but how has it impacted innovation, especially in the health and healthcare sector? Most obviously, the industry has seen a massive wave of investment, innovation and new entrants from the technology, telecom and consumer industries.

Leading U.S. health, educational and research organizations have come together with the creation of a group aimed at accelerating artificial intelligence innovation and adoption in healthcare, Microsoft announced Thursday. The Artificial Intelligence Industry Innovation Coalition (AI3C) will leverage the collective brainpower, experience and expertise of the Brookings Institution, Cleveland Clinic, Duke Health, Intermountain Healthcare, Microsoft, Novant Health, Plug and Play, Providence, UC San Diego, and University of Virginia. From diagnosing and treating disease to addressing disparities in care, overcoming social barriers, speeding research and reducing physician burnout, artificial intelligence has the power to overhaul healthcare, according to leaders of the new coalition. To get there, AI3C is honing in on some core goals. Those include showcasing new AI innovations, gathering industry-specific information on how AI is used, developing best practices for responsible AI implementation and preparing students for careers in AI and data science. "Meeting the urgent need for new health technologies requires diverse partners coming together across sectors," Ashley Llorens, vice president and managing director for Microsoft Research and Incubations, said in a news release announcing the coalition.

From the stethoscope to the CT scanner, technology and healthcare have long gone hand in hand. But the difficulty, especially in an age when budgets are stretched and digital innovations are proliferating, is deciding which technologies will deliver the biggest public health benefits. These need not be cutting-edge innovations. One important step is simply to replace existing analogue systems with digital ones, says David Maguire, senior analyst in the policy team at health think-tank the King's Fund. This year, Maguire co-authored a report that analysed the evidence on digital technology in health and social care. Among the most promising areas it identified was communications, both internally and when dealing with patients.

From remote surgery to rehabilitation robotics and wearable sensors, 5G will be a real driver of innovation in healthcare, helping improve staff efficiency while improving patient care. For example, in Milan, the 5G connected ambulance is allowing paramedics to be continuously connected to the emergency management centre and with hospital doctors, providing a way to share patient details and symptoms before they even reach the hospital. As the "5G capital of Europe", Milan has been at the forefront of innovation in this area and recently acted as the backdrop for our 5G Healthcare Vodafone Conference & Experience Day – an event dedicated to the future of Health and Wellness. Attended by the industry's leading figures, we discussed the key role that new technologies are playing and shared some of our recent breakthroughs. During the event, a remote surgery operation was carried out for the first time in Italy on our live 5G network in collaboration with the Italian Institute of Technology (IIT) and the IRCSS Hospital San Raffaele.

The COVID-19 pandemic has created numerous challenges in healthcare, but challenges can sometimes breed innovation. Technological innovation in particular is poised to change the way care is delivered, driving efficiency in the process. Efficiency will be key as hospitals and health systems look to recover from the initial, devastating wave of the pandemic. Ryan Hodgin, chief technology officer for IBM Global Healthcare, and Kate Huey, partner at IBM Healthcare, will speak about some of these technological innovations in their digital HIMSS21 session, "Innovation Driven Resiliency: Redefining What's Possible." The technology in question can encompass telehealth, artificial intelligence, automation, blockchain, chatbots, apps and other elements that have become mainstays of healthcare during the course of the pandemic.

An honest dialogue about a subject that is heartfelt to so many people around the world. Intel Corporation, and the team at Enzolytics, present a vision for the future of the Use of Artificial Intelligence for Social Good. As the pandemic has shown us, we are all in this together." It affects not only a person, family, community, or country but the entire world. Intel and Enzolytic's collaborative white paper(published earlier) titled "Optimizing Empathetic A.I. to Cure Deadly Diseases," [https://lnkd.in/dx5VKhg] We invite Government organizations, policymakers, biotechnology companies to join Enzolytics and Intel's vision of the future to find answers to the pandemic and transform healthcare.

"Let Sleeping Patients Lie, avoiding unnecessary overnight vitals monitoring using a clinically based deep-learning model": Researchers from New Hyde Park, N.Y.-based Northwell Health's research arm developed an artificial intelligence tool to predict which patients will remain stable overnight and don't need to be awoken for vital monitoring. The tool cut in half the number of patients who were awoken during the night for vital sign checks, misclassifying less than two of 10,000 cases. "Evaluation of the use of combined artificial intelligence and pathologist assessment to review and grade prostate biopsies": Researchers developed an artificial intelligence tool to improve pathologists' grading of prostate needle biopsies, finding significant increases in grading agreement. "Development and validation of a real-time artificial intelligence-assisted system for detecting early gastric cancer: A multicentre retrospective diagnostic study": The research team developed and validated a real-time deep convolutional neural networks system for the detection of early gastric cancer. "Artificial intelligence algorithm for detecting myocardial infarction using six-lead electrocardiography": Researchers developed a deep learning-based artificial intelligence algorithm to help detect myocardial infarction using electrocardiography to speed up the diagnosis process.